X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 3,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 3,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 62,874 | 51,703 | 29,085 | 22,247 | 24,346 |
| Operating Income | -59,874 | -51,703 | -29,085 | -22,247 | -24,346 |
| Interest Expense | 2,688 | 2,147 | 720 | 490 | 2,515 |
| Other Income | 579 | 1,043 | -3,480 | 743 | 3,886 |
| Pre-tax Income | -61,983 | -52,807 | -33,285 | -21,994 | -22,975 |
| Income Tax | 148 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -62,131 | -52,807 | -33,285 | -21,994 | -22,975 |
| Net Income | $-62,131 | $-52,807 | $-33,285 | $-21,994 | $-22,975 |
| EPS Basic Total Ops | -92.79 | -139.04 | -2,376.88 | -1,639.04 | -8,068.66 |
| EPS Basic Continuous Ops | -92.93 | -137.54 | -2,177.67 | -1,442.10 | -8,059.58 |
| EPS Diluted Total Ops | -92.79 | -139.04 | -2,376.88 | -1,639.04 | -8,068.66 |
| EPS Diluted Continuous Ops | -92.93 | -137.54 | -2,177.67 | -1,442.10 | -8,059.58 |
| EPS Diluted Before Non-Recurring Items | -92.79 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-59,523 | $-51,600 | $-28,982 | $-22,176 | $-24,061 |